Ava C. Carter
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- RNA modifications and cancer
- Pluripotent Stem Cells Research
- RNA Research and Splicing
- CRISPR and Genetic Engineering
- Cancer-related gene regulation
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
Papers in
-
- CRISPR and Genetic Engineering 7
- Genomics and Chromatin Dynamics 5
- Epigenetics and DNA Methylation 4
- Pluripotent Stem Cells Research 3
- RNA modifications and cancer 3
- RNA Research and Splicing 3
- Genetics 4
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 2
- Co-authors
- Howard Y. Chang (10 shared papers)Jin Xu (6 shared papers)Kevin Eggan (3 shared papers)Justin K. Ichida (3 shared papers)Kathryn Koszka (2 shared papers)K. Daneshvar (1 shared paper)Marius Wernig (1 shared paper)Peter C. Dedon (1 shared paper)
- Journals
- Cell stem cell (2 papers)Nature Methods (2 papers)Nature (2 papers)eLife (2 papers)Stem Cell Reports (1 paper)
- Partner nations
- United StatesFranceJapan
In The Last Decade
Ava C. Carter
15 papers receiving 2.9k citations
Ava C. Carter's Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 748
- Molecular Biology 2.6k
- Genetics 310
- Aging 19
- Developmental Neuroscience 34
Countries citing papers authored by Ava C. Carter
This map shows the geographic impact of Ava C. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ava C. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ava C. Carter more than expected).
Fields of papers citing papers by Ava C. Carter
This network shows the impact of papers produced by Ava C. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ava C. Carter. The network helps show where Ava C. Carter may publish in the future.
Co-authors
The 25 scholars most cited alongside Ava C. Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells Hit paper breakdown → | 2014 | 985 |
| 2 | A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog Hit paper breakdown → | 2009 | 664 |
| 3 | 2018 | 330 | |
| 4 | 2016 | 294 | |
| 5 | 2016 | 171 | |
| 6 | 2018 | 138 | |
| 7 | 2017 | 61 | |
| 8 | 2014 | 57 | |
| 9 | 2017 | 53 | |
| 10 | 2020 | 41 | |
| 11 | 2021 | 37 | |
| 12 | 2014 | 35 | |
| 13 | 2017 | 25 | |
| 14 | 2018 | 13 | |
| 15 | 2021 | 13 |
About Ava C. Carter
Ava C. Carter is a scholar working on Molecular Biology, Genetics, Cancer Research, Plant Science and Surgery, having authored 15 papers that have together received 2.9k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), Genomics and Chromatin Dynamics (5 papers), Epigenetics and DNA Methylation (4 papers), Pluripotent Stem Cells Research (3 papers), RNA modifications and cancer (3 papers), RNA Research and Splicing (3 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers) and Chromosomal and Genetic Variations (2 papers). The work is most often cited by research in Cancer Research (748 citations), Molecular Biology (2.6k citations), Genetics (310 citations), Aging (19 citations) and Developmental Neuroscience (34 citations). Ava C. Carter has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Howard Y. Chang, Jin Xu, Kevin Eggan, Justin K. Ichida, Kathryn Koszka, K. Daneshvar, Marius Wernig, Peter C. Dedon, Lingjie Li and Yi Xing. Their work appears in journals such as Cell stem cell, Nature Methods, Nature, eLife and Stem Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.